Eterna Therapeutics Inc
Change company Symbol lookup
Select an option...
ERNA Eterna Therapeutics Inc
RS Reliance Steel & Aluminum Co
DNA Ginkgo Bioworks Holdings Inc
BEN Franklin Resources Inc
FLFG Federal Life Group Inc
GIIXU Gores Holdings VIII Inc
AEE Ameren Corp
SSRM SSR Mining Inc
GDRX Goodrx Holdings Inc
SEDG Solaredge Technologies Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Eterna Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing advanced therapies using Messenger RNA (mRNA) cell engineering technology. The Company is engaged in developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its product pipeline is based on patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. It formulates mRNA using lipid nanoparticle (LNP) technology. The ToRNAdo delivery system surrounds and protects the mRNA cargo, enabling delivery into human cells. The Company has licensed a portfolio of over 100 patents covering key cell engineering technologies, including therapeutic gene editing in clinical development. It has multiple cell and gene-editing therapies in preclinical development for various indications.

The symbol you entered, BTX, changed to ERNA.

Day's Change
0.26 (8.39%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 12,011 shares is on pace to be much greater than ERNA's 10-day average volume of 8,100 shares.




6 providers

No press release found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.